/
BCLI
$0.90-$0.03 (-3.22%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.46 – $1.32
51% from low
Exchange
OTC Link
CS
Borrow rate
15.91%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-56.10
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | −$366.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $110.0K | $366.0K | $219.0K | $260.0K | $285.0K | $265.0K | $240.0K | $0 |
| Gross profit | −$110.0K | −$732.0K | −$219.0K | −$260.0K | −$285.0K | −$265.0K | −$240.0K | $0 |
| Gross margin | — | 200.0% | — | — | — | — | — | — |
| R&D | $8.3M | $17.2M | $22.3M | $15.2M | $14.0M | $10.5M | $4.4M | $4.2M |
| Operating income | −$14.1M | −$23.0M | −$31.7M | −$24.5M | −$24.8M | −$21.4M | −$11.7M | −$10.0M |
| EBITDA | −$13.8M | −$23.1M | −$31.5M | −$24.3M | −$24.0M | −$16.9M | −$11.3M | −$9.8M |
| Net income | −$13.9M | −$23.3M | −$31.8M | −$24.5M | −$24.3M | −$17.2M | $11.6M | −$10.3M |
| Net margin | — | 6353.3% | — | — | — | — | — | — |
| EPS (diluted) | -10.05 | -13.64 | -14.09 | -10.09 | -9.93 | -4.48 | 2.19 | -1.11 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $427M | $-1.07 | $-1.07–$-1.07 | 1 |
| 2027 | $446M | $-0.86 | $-0.86–$-0.86 | 1 |
| 2028 | $33M | $-0.39 | $-0.39–$-0.39 | 1 |
| 2029 | $51M | $-0.07 | $-0.07–$-0.07 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
BRAINSTORM CELL THERAPUTC
BRAINSTORM CELL THERAPUTC
Held by traders on TradeandTell
No one on the platform currently holds BCLI.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BCLI as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-10-01 | 1-for-15reverse |
| 2014-09-16 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded BCLI yet.
